Intrapulmonary Percussive Ventilation Therapy: Clinical Impact & Utility
IPV therapy is a safe and well-tolerated airway clearance therapy that can be used with a diverse set of patient populations, care settings, and delivery interfaces.
IPV therapy is a safe and well-tolerated airway clearance therapy that can be used with a diverse set of patient populations, care settings, and delivery interfaces.
The IPV Therapy Clinical Evidence Brochure offers an overview of key clinical studies that highlight the efficacy and safety of intrapulmonary percussive ventilation (IPV) therapy across diverse patient populations. This brochure provides healthcare professionals with an understanding of the clinical utility and benefits of IPV therapy as demonstrated in the available evidence.
Sentec transcutaneous technology overcomes many of the current limitations and challenges associated with CO2 measurement in the NICU by providing accurate, continuous, noninvasive CO2 values regardless of ventilation method or V/Q mismatch.
Sentec transcutaneous technology overcomes limits of pulse oximetry, arterial blood draws and capnography with continuous CO2 monitoring that combines ease of use and patient comfort, with accurate values regardless of ventilation method or ventilation/perfusion (V/Q) mismatch, and product features designed for sleep care settings.Sentec transcutaneous technology overcomes limits of pulse oximetry, arterial blood draws and capnography with continuous CO2 monitoring that combines ease of use and patient comfort, with accurate values regardless of ventilation method or ventilation/perfusion (V/Q) mismatch, and product features designed for sleep care settings.
The Sentec suite of attachment options for transcutaneous CO2 monitoring allows care teams to confidently choose solutions that support the clinical priorities of each patient — across populations and care settings.
CE Webinar Thursday, March 20th, [...]
Webinar Wednesday, March 19, 2025 [...]
CE Webinar Wednesday, March 12, [...]
Webinar Thursday, March 6, 2025 [...]
Webinar Thursday, February 27, 2025 [...]